307 related articles for article (PubMed ID: 20419814)
1. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
2. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
Jones CA; Taylor TJ; Knipe DM
Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
[TBL] [Abstract][Full Text] [Related]
4. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice.
Pelosi E; Rozenberg F; Coen DM; Tyler KL
Virology; 1998 Dec; 252(2):364-72. PubMed ID: 9878615
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
6. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
[TBL] [Abstract][Full Text] [Related]
9. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
10. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of the reproduction of a herpes simplex I virus carrying mutations in the thymidine kinase and DNA polymerase genes].
Galegov GA; Nikolaeva SN; Gibadullin RA; Zhdanov VM
Genetika; 1986 May; 22(5):892-4. PubMed ID: 3015723
[TBL] [Abstract][Full Text] [Related]
13. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
15. The essential in vivo function of the herpes simplex virus UL42 protein correlates with its ability to stimulate the viral DNA polymerase in vitro.
Reddig PJ; Grinstead LA; Monahan SJ; Johnson PA; Parris DS
Virology; 1994 May; 200(2):447-56. PubMed ID: 8178434
[TBL] [Abstract][Full Text] [Related]
16. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
17. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.
Bertke AS; Patel A; Krause PR
J Virol; 2007 Jun; 81(12):6605-13. PubMed ID: 17409161
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
